• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Gimv

Pan-European GPs putting feet on the ground in Benelux
Pan-European GPs putting feet on the ground in Benelux

Pan-European GPs seek to tap Benelux's burgeoning buyout dealflow by securing talent familiar with the region

  • People
  • 24 January 2018
Stage Capital exits STI Group in SBO
Stage Capital exits STI Group in SBO

French plastic medical devices manufacturer is sold to Mérieux Développement and Gimv

  • Exits
  • 18 January 2018
Gimv sells Mackevision to Accenture
Gimv sells Mackevision to Accenture

Acquisition adds further visualisation capabilities to Accenture's digital services portfolio

  • Exits
  • 10 January 2018
Benelux funds specialise to compete with strategic buyers
Benelux funds specialise to compete with strategic buyers

Record level of commitments were secured by Benelux funds during 2017, with GPs increasingly turning to sector specialisation

  • Fundraising
  • 19 December 2017
Gimv sells Brakel via trade sale
Gimv sells Brakel via trade sale

Gimv sells natural climate control and fire safety specialist Brakel to Kingspan

  • Exits
  • 27 November 2017
Gimv buys Agrobiothers
Gimv buys Agrobiothers

Jenoudet family will reinvest in the new company in return for a significant minority stake

  • Buyouts
  • 22 November 2017
Paragon, Gimv team up on Wemas buyout
Paragon, Gimv team up on Wemas buyout

Paragon's involvement is announced eight weeks after Gimv's initial buyout

  • Buyouts
  • 17 November 2017
Gimv, UI Gestion sell Almaviva Santé to Antin
Gimv, UI Gestion sell Almaviva Santé to Antin

Gimv and UI Gestion sell the French private hospitals group to Antin Infrastructure Partners

  • Buyouts
  • 25 October 2017
Gimv sells Luciad to Hexagon
Gimv sells Luciad to Hexagon

Sale ends a four-year holding period for Gimv, which acquired the company in June 2013

  • Exits
  • 04 October 2017
Nord Holding sells Wemas to Gimv
Nord Holding sells Wemas to Gimv

Sale ends a six-year holding period for Nord Holding, which acquired the company in 2011

  • Buyouts
  • 25 September 2017
Gimv acquires 23.6% stake in Cegeka
Gimv acquires 23.6% stake in Cegeka

GP plans to support the company's growth, both organically and by means of acquisitions

  • Expansion
  • 21 September 2017
Gimv buys stake in Snack Connection
Gimv buys stake in Snack Connection

Food production investor Trophas first acquired an interest in Snack Connection in February 2016

  • Expansion
  • 07 July 2017
Gimv invests €15m in Arseus Medical
Gimv invests €15m in Arseus Medical

GP will draw capital for the transaction from its €150m Health & Care Fund, closed in March 2014

  • Expansion
  • 07 July 2017
Gimv sells stake in RES to Ivanti
Gimv sells stake in RES to Ivanti

Deal ends a seven-year holding period for Gimv, which initially invested in the company in April 2010

  • Exits
  • 06 July 2017
Pragma and Gimv exit Leyton & Associés
Pragma and Gimv exit Leyton & Associés

Pragma Capital and Gimv became shareholders in Leyton & Associés in 2009 when they backed the company's second MBO

  • Exits
  • 13 June 2017
Gimv acquires stake in MVZ Holding
Gimv acquires stake in MVZ Holding

Gimv will provide financial and strategic support for MVZ Holding’s growth and acquisition strategy

  • Expansion
  • 10 May 2017
BIVF at al. lead €20m series-A for ImCheck Therapeutics
BIVF at al. lead €20m series-A for ImCheck Therapeutics

Backers include Kurma Partners, Idinvest, Gimv and Life Sciences Partners

  • Early-stage
  • 03 May 2017
Altice acquires VC-backed Teads for €285m
Altice acquires VC-backed Teads for €285m

Founded in 2005, the tech startup has reportedly raised a total of $127.7m in funding since inception

  • Exits
  • 22 March 2017
Gimv in €7.8m series-B round for AgroSavfe
Gimv in €7.8m series-B round for AgroSavfe

GP previously led a €5m round for the Belgian agro-biotech group in 2013

  • Expansion
  • 08 March 2017
Gimv, Sofinnova in €43.5m round for Breath Therapeutics
Gimv, Sofinnova in €43.5m round for Breath Therapeutics

Company will use the financing to conduct phase III trials of its inhalation therapy in Europe and the US

  • DACH
  • 08 March 2017
Gimv leads €10.3m round for Itineris
Gimv leads €10.3m round for Itineris

Fourth funding round brings total raised by Flemish group to over €30m

  • Expansion
  • 26 January 2017
Gimv sells Multiplicom to Agilent Technologies for €68m
Gimv sells Multiplicom to Agilent Technologies for €68m

GP claims a return on the sale above its long-term average return rate

  • Exits
  • 22 December 2016
Gimv takes 40% stake in Mega International
Gimv takes 40% stake in Mega International

Gimv invested in the Parisian tech company through its Smart Industries platform

  • Buyouts
  • 25 October 2016
Private equity's public market problems
Private equity's public market problems

Despite strong investor appetite for listed private equity houses, life on the public markets brings with it numerous challenges

  • GPs
  • 18 October 2016
234
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013